GALT (Galectin Therapeutics) Kacepetan wutah bathi saben saham ing taun lumaku

Simbol resmi perusahaan galectintherapeutics.com (GALT)

Galectin Therapeutics (GALT) is protected by patents for combating cirrhosis and strict FDA oversight, while the firm's environmental footprint remains minimal. Year-over-year EPS dynamics on the GURU.Markets chart demonstrate business resilience, where the current parameter equals 37.50. The company is highly regarded within the scientific community for its deep expertise in fibrosis therapy and its pursuit of solutions for severe pathologies.

GALT (Galectin Therapeutics, Inc.) riwayat Wutah bathi ing taun lumaku saka 04.07.2022 nganti 15.11.2026

Rincian analitis lan laporan data perusahaan Galectin Therapeutics, Inc. (GALT)

- rega saham lan konsensus proyeksi valuasi:
Bagan rega Galectin Therapeutics, Inc.|GALT - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Nilai pasar Galectin Therapeutics Inc.|GALT - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi Saham Galectin Therapeutics|GALT - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas galectintherapeutics.com|GALT - Total Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal Galectin Therapeutics|GALT - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Galectin Therapeutics, Inc.|GALT - Gunggung utang perusahaan|Utang-utang marang nilai buku Galectin Therapeutics|GALT - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Galectin Therapeutics|Rasio likuiditas perantara galectintherapeutics.com
- indikator pendapatan resik lan kelipatan nilai:
GALT - Bathi resik|Prakiraan bathi perusahaan Galectin Therapeutics|GALT - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Galectin Therapeutics|GALT - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Galectin Therapeutics, Inc.|GALT - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Galectin Therapeutics|GALT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan galectintherapeutics.com|GALT - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Galectin Therapeutics
- informasi babagan volume dodolan lan pendapatan:
GALT - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan Galectin Therapeutics, Inc.|GALT - Multiplikator P/S|Multiplikator Forward P/S Galectin Therapeutics Inc.
Pambiji fundamental:GALT Galectin Therapeutics
Produk asil prodhuksi Galectin Therapeutics Inc.

For Galectin Therapeutics (GALT), the annual percentage growth of net income per share serves as an indicator of financial stability amid costly clinical trials for cirrhosis drugs. This metric captures EPS dynamics relative to the previous year, allowing for an assessment of how effectively the company manages capital and minimizes cash flow gaps while awaiting regulatory approvals and scientific validation of inhibitor efficacy.

Pesaing langsung

ARWR (Arrowhead Pharmaceuticals Inc) - Wutah bathi saben saham ing taun lumaku|MIRM (Mirum Pharmaceuticals, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Dynavax Technologies Corporation DVAX|Wutah bathi saben saham ing taun lumaku Arbutus Biopharma Corporation (ABUS)|Prakiraan wutah bathi resik saben saham ing taun iki Inventiva SA|Wutah bathi ing taun lumaku GYRE (Gyre Therapeutics Inc)|Wutah bathi ing taun lumaku Assembly Corp ASMB|Genfit Corp - Wutah bathi ing taun lumaku|DRRX - Wutah bathi ing taun lumaku|ALGS: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku BioVie Inc. (BIVI)|Wutah bathi saben saham ing taun lumaku galmedpharma.com|NDRA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Hepion Pharmaceuticals (HEPA)